Close

Acorda Therapeutics (ACOR) Tops Q1 EPS by 1c

April 30, 2015 6:06 AM EDT

Acorda Therapeutics (NASDAQ: ACOR) reported Q1 EPS of $0.15, $0.01 better than the analyst estimate of $0.14. Revenue for the quarter came in at $99.85 million versus the consensus estimate of $100.2 million.

For earnings history and earnings-related data on Acorda Therapeutics (ACOR) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings